Back to Search Start Over

Very-Low-Dose Radiation and Clinical Molecular Nuclear Medicine

Authors :
Chi-Jung Tsai
Kang-Wei Chang
Bang-Hung Yang
Ping-Hsiu Wu
Ko-Han Lin
Ching Yee Oliver Wong
Hsin-Lun Lee
Wen-Sheng Huang
Source :
Life, Vol 12, Iss 6, p 912 (2022)
Publication Year :
2022
Publisher :
MDPI AG, 2022.

Abstract

Emerging molecular and precision medicine makes nuclear medicine a de facto choice of imaging, especially in the era of target-oriented medical care. Nuclear medicine is minimally invasive, four-dimensional (space and time or dynamic space), and functional imaging using radioactive biochemical tracers in evaluating human diseases on an anatomically configured image. Many radiopharmaceuticals are also used in therapies. However, there have been concerns over the emission of radiation from the radionuclides, resulting in wrongly neglecting the potential benefits against little or any risks at all of imaging to the patients. The sound concepts of radiation and radiation protection are critical for promoting the optimal use of radiopharmaceuticals to patients, and alleviating concerns from caregivers, nuclear medicine staff, medical colleagues, and the public alike.

Details

Language :
English
ISSN :
20751729
Volume :
12
Issue :
6
Database :
Directory of Open Access Journals
Journal :
Life
Publication Type :
Academic Journal
Accession number :
edsdoj.5c5c19b20e4a42d2aa22b5104a86a8b7
Document Type :
article
Full Text :
https://doi.org/10.3390/life12060912